Pay in 4 interest-free payments of $7.03 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
Instead of jumping between advice, plans, and guesswork, you get a structured system designed to support real life
Secondary endpoints included in-stent restenosis and non-target lesion progression
486,487,488 Notably, filgotinib has good oral availability, reaching maximum plasma concentrations at 13 h and plasma steady-state concentrations on day 2, making it a promising biologic agent for the treatment of UC
How are dose adjustments determined
US$ 25.33
US$ 27.81
US$ 21.60
